Skin Reaction After Cancer Treatment
Author Information
Author(s): Vihinen Pia, Paija Outi, Kivisaari Atte, Koulu Leena, Aho Heikki
Primary Institution: Turku University Hospital
Hypothesis
Can paclitaxel and bevacizumab cause cutaneous lupus erythematosus in patients without a history of autoimmune disorders?
Conclusion
Cutaneous lupus erythematosus can occur in patients without prior autoimmune disorders after treatment with paclitaxel and bevacizumab.
Supporting Evidence
- Paclitaxel and bevacizumab are commonly used in cancer treatment.
- Skin disorders are rare side effects of these drugs.
- The patient had no prior autoimmune history.
Takeaway
One woman developed a skin condition after cancer treatment, even though she had no previous skin problems. Stopping the treatment made her skin better.
Methodology
Case report of a 65-year-old woman treated with paclitaxel and bevacizumab for metastatic breast cancer.
Limitations
Only one case is reported, limiting generalizability.
Participant Demographics
65-year-old Caucasian woman.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website